Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
03/2009
03/12/2009US20090069225 Somatostatin analogues
03/12/2009US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1
03/12/2009US20090068176 Human neutralizing antibodies aganst hemolytic uremic syndrome
03/12/2009US20090068152 Gene transfer for regulating smooth muscle tone
03/12/2009US20090068101 A1 Adenosine Receptor Antagonists
03/12/2009CA2698377A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis
03/11/2009EP2033972A1 Screening method for candidate drugs
03/11/2009EP2033953A1 Vanilloid receptor modulators
03/11/2009EP2033951A2 2-Piperazine-pyridines useful for treating pain
03/11/2009EP2033651A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
03/11/2009EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
03/11/2009EP2033644A1 Spiroindene and spiroindane compounds
03/11/2009EP2033634A1 Agent for increasing testosterone level
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto
03/11/2009EP1305409B1 Renal regulatory elements and methods of use thereof
03/11/2009CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
03/11/2009CN101384266A Fixed-dose association of phytate and zinc
03/11/2009CN101384261A Method and composition for treating pain
03/11/2009CN101380456A Traditional Chinese medicine for treating infantile bed-wetting
03/11/2009CN101380409A Broadspectrum antiphlogistic traditional Chinese medicine
03/11/2009CN101380365A Baicao Shenqing traditional Chinese medicine composition and preparation method thereof
03/11/2009CN101380121A Preparation method of duck steamed with Jing bamboo
03/11/2009CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives
03/11/2009CN100467035C Medicine for treating frequent micturition and its preparaton method
03/10/2009US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents
03/10/2009US7501443 Flavaxate derivatives as muscarinic receptor antagonists
03/10/2009US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/10/2009US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration
03/10/2009CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same
03/05/2009WO2009028618A1 Piperidine derivative
03/05/2009WO2009028543A1 Substituted pyrazole derivative
03/05/2009WO2009027994A2 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL
03/05/2009WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury
03/05/2009WO2008108322A3 Composition and method for protecting mitochondria
03/05/2009US20090062398 Deuterium-enriched tolterodine
03/05/2009US20090062387 Method of preventing nephrocalcinosis
03/05/2009US20090062385 Deuterium-enriched fesoterodine
03/05/2009US20090062373 Deuterium-enriched pf-184298
03/05/2009US20090062345 Amide derivatives as trpv1 antagonists
03/05/2009US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer
03/05/2009US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals)
03/05/2009US20090060944 Enhancer Of The Effect Of Adrenocorticoid,Comprising Gum Arabic
03/05/2009US20090060937 Immunostimulatory oligonucleotides and uses thereof
03/05/2009US20090060925 Rage Fusion Proteins and Methods of Use
03/05/2009US20090060922 Acetamide Stereoisomer
03/05/2009CA2697663A1 Substituted pyrazole derivative
03/05/2009CA2696799A1 Piperidine derivative
03/04/2009EP2029617A2 N-oxides of kappa opioid receptor peptides
03/04/2009EP2029134A1 Stabilized pharmaceutical compositions comprising fesoterodine
03/04/2009EP2029131A2 Method for treating renal disease
03/04/2009EP2029128A2 Method of treatment of chronic nonbacterial prostatitis with selective estrogen receptor modulators or aromatase inhibitors
03/04/2009EP1506951B1 Method for the preparation of total salvianolic acid
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009EP1472209B1 Lipoxin a4 analogs
03/04/2009EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
03/04/2009EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists
03/04/2009EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity
03/04/2009CN101379040A Muscarinic receptor antagonists
03/04/2009CN101378767A Stabilized lanthanum carbonate compositions
03/04/2009CN101376008A Pure medicinal formulation for tonifying kidney and dreplenishing essence and preparation method thereof
03/04/2009CN101375989A Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof
03/04/2009CN101375988A Anti-inflammation formulation for treating acute prostatitis and preparation method thereof
03/04/2009CN101375987A Anti-inflammation formulation for treating chronic prostatitis and preparation method thereof
03/04/2009CN101375858A Solid formulation of urea nitrogen sorbent for compensating kidney function and preparation method thereof
03/04/2009CN100465186C A composition and a method for inhibiting platelet aggregation
03/04/2009CN100465171C A preparation method of potassium sodium dehydroandroan drographolide succinate, a potassium sodium dehydroandroan drographolide succinate preparation and a preparation method thereof
03/04/2009CN100464781C Nutrition liquid for chronic nephropathy and a preparation method thereof
03/04/2009CN100464777C A medicine for treating prostatosis and a preparation method thereof
03/03/2009US7498358 Human ADAM-10 inhibitors
03/03/2009US7498352 TGF-β superfamily production/secretion promoter
03/03/2009US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect
03/03/2009US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors
03/03/2009US7498323 Spiro-piperidine compounds and medicinal use thereof
03/03/2009US7498303 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular
03/03/2009US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
03/03/2009CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
02/2009
02/26/2009WO2009026517A2 Therapy for complications of diabetes
02/26/2009WO2008022761A3 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders
02/26/2009US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias
02/26/2009US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
02/26/2009US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same
02/26/2009US20090054462 Hydroisoindoline tachykinin receptor antagonists
02/26/2009US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol
02/26/2009US20090054341 Methods of Treatment Using Exendin Peptides or GLP-1 Peptides
02/26/2009US20090054336 Binding Agent
02/26/2009US20090054302 Methods and Preparations For Curing Clinically Ill Patients
02/26/2009US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom
02/26/2009US20090053231 Optical Disc Apparatus
02/26/2009CA2697057A1 Therapy for complications of diabetes
02/25/2009EP2028187A1 Human and mouse targeting peptides identified by phage display
02/25/2009EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease
02/25/2009EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
02/25/2009EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/25/2009CN101374844A Pyrrolopyridazinone compound
02/25/2009CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI
02/25/2009CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
02/25/2009CN101371908A Gelatin-coated pill for preventing and treating calculi in vivo